FiledFeed

Feed News Companies Sectors Leaderboards Learn

Log in Sign up

MERA PHARMACEUTICALS INC

CIK 0000837490

Log in to watch

← back to feed

Revenue (TTM)

—

Q3 Jul 2012

Net Income (TTM)

—

Q3 Jul 2012

EPS Diluted (TTM)

—

Q3 Jul 2012

Gross Margin

—

Q3 Jul 2012

Operating Margin

—

Q3 Jul 2012

Net Margin

—

Q3 Jul 2012

Free Cash Flow (TTM)

—

Q3 Jul 2012

Cash

$4.01K

Q3 Jul 2012

Total Debt

—

Q3 Jul 2012

Shares Outstanding

557.3M sh

Q3 Jul 2012

Recent filings

8-K Material Event

Oct 15, 2021 details → sec.gov ↗

8-K Material Event

Sep 16, 2021 details → sec.gov ↗

8-K Material Event

Sep 10, 2021 details → sec.gov ↗

8-K Material Event

Jun 30, 2021 details → sec.gov ↗

8-K Material Event

Jun 17, 2021 details → sec.gov ↗

8-K Material Event

Jun 7, 2021 details → sec.gov ↗

8-K Material Event

Mar 23, 2021 details → sec.gov ↗

8-K Material Event

Mar 18, 2021 details → sec.gov ↗

8-K Material Event

Dec 21, 2020 details → sec.gov ↗

10-K Annual Report

Jul 23, 2013 details → sec.gov ↗

10-Q Quarterly Report

Jul 26, 2012 details → sec.gov ↗

10-Q Quarterly Report

Jul 26, 2012 details → sec.gov ↗

10-Q Quarterly Report

Jul 26, 2012 details → sec.gov ↗

8-K Material Event

Jul 10, 2012 details → sec.gov ↗

10-K Annual Report

Feb 10, 2012 details → sec.gov ↗

8-K/A Material Event

Jun 24, 2011 details → sec.gov ↗

8-K Material Event

Jun 15, 2011 details → sec.gov ↗

NT 10-K Annual Report

Jan 31, 2011 details → sec.gov ↗

10-Q Quarterly Report

Sep 14, 2010 details → sec.gov ↗

10-Q Quarterly Report

Jun 14, 2010 details → sec.gov ↗